# FDA recall D-1224-2014

> **American Lifestyle.Com** · Class I · drug recall initiated 2013-04-30.

## Product

Black Ant, 4600 mg x 4.  Product is packaged in a small green box with gold lettering on the front, the back side of the box contains mostly foreign character.  Within the box there are four (4) capsules individually wrapped in black and red plastic with white lettering.  UPC 4026666142546 (product numbers may possibly vary for same product identification and same product packaging).

## Reason for recall

Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil.   Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs.

## Distribution

Domestic distribution currently under Investigation; International distribution includes, but may not be limited to the following countries : Mexico, France, Brazil, Belgium, Denmark, Switzerland, Spain, Canada, Italy, Japan, Ireland, Venezuela, Oman.

## Key facts

- **Recall number:** D-1224-2014
- **Recalling firm:** American Lifestyle.Com
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-04-30
- **Report date:** 2014-04-16
- **Termination date:** 2018-06-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Pittsford, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1224-2014

## Citation

> AI Analytics. FDA recall D-1224-2014. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1224-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*